艾布魯(301259.SZ):擬使用部分超募資金7262.52萬元投入9個建制鎮污水處理特許經營項目
格隆匯7月5日丨艾布魯(301259.SZ)公佈,公司第二屆董事會第十七次會議決議,審議通過《關於使用部分超募資金投資建設項目的議案》,擬使用首次公開發行股票募集資金中的部分超募資金人民幣7262.52萬元投入洞口縣毓蘭鎮等9個建制鎮污水處理特許經營項目,公司將使用其中5000萬元實繳全資子公司洞口艾布魯環境工程有限公司(“洞口艾布魯”)註冊資本,未來將由全資子公司洞口艾布魯負責洞口縣毓蘭鎮等9個建制鎮污水處理特許經營項目的投融資、建設、運營維護、移交等工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.